GCP Inspection Findings published

Recommendation
18-20 November 2025
Heidelberg, Germany
GMP and FDA Compliance in Pharmaceutical Development and IMP Manufacturing
The U.K. Medicines and Healthcare Products Regulatory Agency MHRA has compiled a GCP Inspections Metrics Report. This report summarises 125 GCP Inspections which were undertaken by the MHRA GCP Inspectorate from 1st April 2013 to 31st March 2014. Now, almost two years later, this interesting overview was published.
When looking at the data, the importance of a robust Quality Management System becomes obvious. Observations in this area are number one for CRO Inspections and number two for Non-Commercial Sponsors closely behind Clinical Trial Oversight. All findings are listed as major grading.
Related GMP News
17.06.2025EMA Policy on the Publication of Clinical Data
17.06.2025EMA Implementation of ICH E6, M11 & M12
03.04.2025Update on the ICH M11 CeSHArP Technical Specification
03.04.2025EU Map to Clinical Trials
03.04.2025EMA Concept Paper on Model Informed Drug Development